Navigation Links
One-Third of Patients Discontinue Common Breast Cancer Therapy

tinuation of Tamoxifen." Cancer 109 (2007): 1-9.

Contact

JFK Communications, Inc.
Eliza Schleifstein, 973-387-0342
efschleifstein@aol.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
2. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
3. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
6. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
9. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
10. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
11. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: One Third Patients Discontinue Common Breast Cancer Therapy
(Date:5/15/2008)...lacks, Hispanics/Latinos, People ...N.J., May 15 /- Daiichi Sankyo, Inc.,...an Society of,Hypertension,s Twenty- Third Annual ...strated that the powerful combination drug AZOR(TM... effectively helped,patients across several major ...
(Date:5/15/2008)...cleared device to identify the, lipid core (fatty... with complications of coronary ...-- InfraReDx, Inc. today,announced that physicians...ccessfully used its LipiScan(TM) Coronary Imaging ...zation. This is the first patient in the,world in ...
(Date:5/15/2008)...ire/ -- Ergonex Pharma today,announced that the Un...,granted orphan drug designation to Terguride for ...PAH). Terguride is currently being evaluated for P...DA,s grant of orphan drug designation to Terguride...t program by offering regulatory,clinical develop...
(Date:5/15/2008)...e/ -- Tigris Pharmaceuticals,Inc. announced today...opment Agreement (CRADA) with the National Cancer ...clinical development of AFP-464, an,aminoflavone c...ted to,metabolites which bind covalently to DNA, r...s part of a four-year CRADA encompassing multiple ...
Breaking Medicine Technology:Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Blood Pressure Drugs Might Prevent Parkinsons 11192 1Blood Pressure Drugs Might Prevent Parkinsons 11192 2Blood Pressure Drugs Might Prevent Parkinsons 11192 3Gerontology conferences highlights to include talks on student social networking 11190 1Gerontology conferences highlights to include talks on student social networking 11190 2Staples Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11188 1Staples Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11188 2The Advisory Board Company to Present at Upcoming Conferences 11186 1The Advisory Board Company to Present at Upcoming Conferences 11186 2
...ase 2 Clinical Trials Initiated, CRANBURY, N.J., M... a biopharmaceutical company developing small,mole...es for the,treatment of a range of human genetic d...tive results from its recently completed,Phase 1 c...te,AT2101) for Gaucher disease at the of Medical ...
...GUNA NIGUEL, Calif.--(BUSINESS WIRE)--Mar 22, 2007...nced today the successful,completion of the analys...dose study of AEOL 10150 ("Study 102"). The clinic...sideration, with the,most likely targets for an ef...diation therapy in lung cancer and/or head and nec...
Other Medicine Technology:Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease 2Amicus Therapeutics Presents Positive Results From Phase 1 Clinical,Studies of Plicera for Gaucher Disease 3Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 2Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 3Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 4
(Date:5/16/2008)...HINGTON, May 16 /PRNewswire-USNewswire/ -- More th...s in the Greater Portland, Oregon and,Vancouver, W...ract as,Teamsters., "The Teamsters are pleased th...act that gives them job protection and a secure re... Jim Hoffa., The workers, both full-time and part...
(Date:5/16/2008)...icine is in a precipitous decline, David C. Dale, ...sicians (ACP), today joined with leading represen... for comprehensive reforms to attract, recruit and...physicians. , During a panel discussion of the ...le and other panelists spoke about the challenges ...
(Date:5/16/2008)...llion for Life-threatening,Disease, BETHESDA, Md....rly,every state will raise funds for cystic fibros...ng in GREAT STRIDES, the largest national CF,fund-...oday., May is National Cystic Fibrosis Awareness ...ic disease that causes fatal lung infections and,s...
(Date:5/16/2008)...liticians - and economists, ORLANDO, Fla., May 1...ters place health care at the top of their "most-i... crunch means none of the health care plans,advanc...s likely to become,law anytime soon, says former U...with Princeton University Health care Economist Uw...
Breaking Medicine News(10 mins):Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3
...man brain can be manipulated to get relief from ch...dies by the Stanford University in California. As ...through showing them scans of their brains while p...rd therapy has not been very successful while trea...
...has been lots of talk about the health benefits of...tudies show that nuts pack a nutritional wallop — ...he Food and Drug Administration has allowed labels...e is good evidence they lower the risk of heart di...
...num toxin A or Botox as it is popularly tagged in ...ation for erasing wrinkles and making the facial s...cle published in the Journal of Cosmetic Dermatolo... just a miracle wrinkle eraser. Botox or BTXA as ...
...has showed that slimmer people mostly commit suici... found that depression level decreased as Body Mas... that people who are overweighed felt very depress...e of it. Professor David Gunnell and his team fro...
Other Medicine News:
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: